MS-HY-STOR-ENERGY/CC&L
19.10.2021 13:05:04 CEST | Business Wire | Press release
Today, Hy Stor Energy LP (Hy Stor Energy) announced its mission to develop and advance the production, storage and delivery of green hydrogen at scale in the United States. Hy Stor Energy, together with its strategic partner Connor, Clark & Lunn Infrastructure (CC&L Infrastructure), will develop, commercialize, and operate large-scale, long-duration hydrogen hubs that will serve as a model for our nation’s green hydrogen development efforts going forward. The first major project, the Mississippi Clean Hydrogen Hub, is under active development and has multiple sites permitted for hydrogen storage.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211019005429/en/
The planned scale of the Mississippi Clean Hydrogen Hub is up to 10 times larger than any other green hydrogen project under consideration in the U.S. and would be one of the largest in the world. During its first phase, the Mississippi Clean Hydrogen Hub is expected to produce an estimated 110 million kilograms (kg) of green hydrogen annually and store more than 70 million kg of green hydrogen in its underground salt caverns. Pending regulatory approvals and equipment availability, the hub’s first phase is planned to enter commercial service by 2025.
“Mississippi's well-established and robust energy network is strategically positioned to support Hy Stor Energy and the growth of a Mississippi hydrogen hub. We welcome this innovative opportunity to share our unique salt dome storage capacity and our trained workforce,” said Lieutenant Governor of Mississippi Delbert Hosemann.
“The biggest challenge the energy transition faces today is how to bridge the gap to allow renewables to replace fossil fuel electric power generation safely and reliably. In an era of increasingly frequent extreme weather, it’s imperative to have the ability to store large quantities of renewable energy capable of providing multiple days of power over long periods of high demand,” said Laura L. Luce, CEO of Hy Stor Energy. “We believe the approach we’re taking in Mississippi will become the blueprint for future green hydrogen projects that not only address the energy transition challenges we face but also bring new jobs, economic revitalization, and low-cost energy to communities in the region. We see this as an important way of advancing U.S. climate leadership.”
“Green hydrogen will play a vital role in the decarbonization of our global societies by offering a viable pathway towards zero emissions,” said Claire Behar, CCO of Hy Stor Energy. “Hy Stor Energy will serve customers across a variety of industries including transportation, power generation, and difficult to decarbonize sectors, such as manufacturing and industrials, where green hydrogen can replace fossil fuels.”
This project will greatly benefit the state of Mississippi’s economy and environment by providing reliable clean energy, while stimulating growth for the long term. The development and commercialization phases are expected to create hundreds of new jobs and attract new manufacturing and industrial companies to the state. The Mississippi Clean Hydrogen Hub will also bring education and workforce development opportunities, supporting the transition to a local and resilient green hydrogen energy system.
“We’re excited to welcome Hy Stor Energy and hydrogen innovators to Mississippi,” said Speaker of the Mississippi House of Representatives Philip Gunn. “Their investment and eventual success here will improve workforce development, bring high paying jobs to our state, and encourage other businesses to invest in the talent and infrastructure we’ve built together.”
“We have worked with a number of cutting-edge and innovative hydrogen-related projects across the world,” said Matt Weaver, Business Lead – North America of Nel Hydrogen. “Based on that experience, we believe that the Mississippi Clean Hydrogen Hub proposed by Hy Stor Energy is truly groundbreaking and can serve as a model for green hydrogen efforts going forward.”
Hy Stor Energy selected Mississippi to develop its first green hydrogen hub because of the state’s distinct geology, strategic geographic location, abundance of available water and renewable energy from the sun and wind, and collaborative business environment. The region boasts multiple naturally occurring underground salt formations that can support development of large caverns, allowing for the safe and effective storage of several years’ worth of green hydrogen. These strategic locations are enhanced by the proximity to existing infrastructure including an array of interstate gas transportation pipelines and electric transmission lines, as well as interstate highways, rail lines, deep water ports, and the Mississippi River.
About Hy Stor Energy
Hy Stor Energy is facilitating the transition to a fossil-free energy environment by developing and advancing green hydrogen at scale through the development, commercialization, and operation of green hydrogen hub projects. Large, fully integrated projects produce, store, and deliver 100% carbon-free energy, providing customers with safe and reliable renewable energy on-demand. Developed as part of an integrated hub, these projects couple on-site green hydrogen production with integrated long-duration storage and distribution – using scale to reduce costs. Hy Stor Energy, led by energy storage industry and hydrogen technology veteran Laura L. Luce, has an innovative team with deep expertise and is positioned as a leader in the green hydrogen revolution. For more information, please visit www.hystorenergy.com .
About Connor, Clark & Lunn Infrastructure
CC&L Infrastructure invests in middle-market infrastructure assets with highly attractive risk-return characteristics, long lives and the potential to generate stable cash flows. The firm has been an active investor and owner of renewable energy assets for more than 15 years. Its portfolio includes more than 60 hydro, solar, and wind facilities totaling 1.4 GW of clean energy generating capacity globally. CC&L Infrastructure is a part of Connor, Clark & Lunn Financial Group Ltd., a multi-boutique asset management firm whose affiliates collectively manage over CAD$100 billion in assets. For more information, please visit www.cclinfrastructure.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211019005429/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
